Patent · US Active

Stable formulations for parenteral injection of small molecule drugs

US9125805B2 · kind B2 · utility

7Cited by
37References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2013
Grant dateSep 8, 2015
Priority date
Expiry dateMay 8, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 μl to 3 ml.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.